Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Senti Biosciences (SNTI) Assets Average (2021 - 2025)

Senti Biosciences has reported Assets Average over the past 5 years, most recently at $52.0 million for Q4 2025.

  • Quarterly results put Assets Average at $52.0 million for Q4 2025, down 33.2% from a year ago — trailing twelve months through Dec 2025 was $52.0 million (down 33.2% YoY), and the annual figure for FY2025 was $74.5 million, down 31.41%.
  • Assets Average for Q4 2025 was $52.0 million at Senti Biosciences, down from $60.6 million in the prior quarter.
  • Over the last five years, Assets Average for SNTI hit a ceiling of $231.8 million in Q3 2021 and a floor of $52.0 million in Q4 2025.
  • Median Assets Average over the past 5 years was $125.6 million (2023), compared with a mean of $131.3 million.
  • Biggest five-year swings in Assets Average: soared 86.55% in 2022 and later tumbled 47.48% in 2024.
  • Senti Biosciences' Assets Average stood at $164.2 million in 2021, then rose by 12.75% to $185.1 million in 2022, then tumbled by 32.14% to $125.6 million in 2023, then plummeted by 38.08% to $77.8 million in 2024, then crashed by 33.2% to $52.0 million in 2025.
  • The last three reported values for Assets Average were $52.0 million (Q4 2025), $60.6 million (Q3 2025), and $75.7 million (Q2 2025) per Business Quant data.